Last weekend, the MedConnectRx team traveled to Phoenix, Arizona to attend one of the most anticipated events in the peptide therapy space — the Peptide World Congress 2026, hosted by the SSRP Institute at the iconic Arizona Biltmore, A Waldorf Astoria Resort. Held over two full days on June 19th and 20th, the Congress brought together thousands of providers, pharmacy owners, clinicians, and industry leaders all united by one mission: advancing evidence-based peptide therapy and improving patient outcomes.
For us at MedConnectRx, attending PWC26 wasn’t just about being in the room — it was about deepening our knowledge, strengthening relationships, and reaffirming our commitment to serving the compounding pharmacy community with the highest-quality active pharmaceutical ingredients available.
A Weekend of Cutting-Edge Peptide Science
The Peptide World Congress is widely regarded as the largest gathering of clinical peptide therapy providers in the country, and 2026 was no exception. With 24+ world-class presenters across 20 sessions and five stages — including the Main Stage in the Frank Lloyd Wright Ballroom — the two-day agenda was packed with actionable, clinically relevant content covering everything from GLP-1 receptor agonists and metabolic care protocols to regenerative medicine, women’s health, genomics, and aesthetics.
Some of the most compelling sessions we attended included discussions on:
- Stacking Regenerative Therapies — exploring how multi-peptide protocols are replacing single-site injection approaches and delivering superior patient outcomes
- GLP-1 and Metabolic Peptide Pharmacology — a deep dive into mono- and dual-agonist protocols, centrally-targeted tri-agonists, and long-term metabolic therapy management that is directly relevant to the APIs we supply
- Precision Medicine and Genomics — understanding how biomarker-guided protocols and each patient’s unique genetic landscape are shaping the next generation of peptide prescribing
- Phenotype-First Prescribing — moving beyond symptom-matching to true cellular-level medicine and individualized dosing strategies
- Regenerative and Longevity Peptides — from tissue-repair compounds and growth factor analogs to emerging multi-peptide stacks redefining performance and longevity care
The event also featured a fascinating keynote panel with Dr. William Seeds, MD — founder of the SSRP Institute and a pioneer in cellular medicine — whose sessions on disease models and adaptive network restoration gave our team a much deeper appreciation for the clinical science driving demand for the APIs we source and supply every day.
Connecting With the Compounding Pharmacy Community
One of the most rewarding parts of PWC26 was the opportunity to connect face-to-face with pharmacy owners and teams we serve — and meet new partners who are pushing the boundaries of what compounding pharmacies can offer their patients.
We had the pleasure of spending time with the teams from:
- South End Pharmacy
- Zenith Pharmacy
- Optimal Balance Pharmacy
- Pure Pharmacy
- Kitch Pharmacy
These are the kinds of forward-thinking pharmacy teams that understand where medicine is heading. Every conversation reinforced why the work we do — ensuring these pharmacies have access to rigorously tested, CoA-verified, FDA-compliant active pharmaceutical ingredients — matters so much. When a pharmacy owner is confident in the quality of their APIs, they can focus entirely on patient care. That’s the partnership we strive to be.
Beyond the pharmacy connections, PWC26 also gave us the chance to engage with thousands of providers — physicians, nurse practitioners, physician assistants, and other clinicians — who are actively prescribing and compounding peptide-based therapies for their patients. Understanding their clinical needs, the compounds they rely on, and the regulatory landscape they navigate helps us continuously improve our sourcing standards and product offerings.
Why Events Like PWC Matter to MedConnectRx
At MedConnectRx, we don’t just ship APIs — we stay embedded in the clinical and regulatory conversation that surrounds them. The pharmaceutical landscape is evolving rapidly, particularly in the peptide space where clinical evidence, FDA guidance, and prescribing trends are shifting year over year. Being present at events like the Peptide World Congress keeps our team sharp, informed, and better equipped to anticipate what our pharmacy partners need next.
The demand for high-quality peptide APIs — semaglutide, tirzepatide, BPC-157, NAD+, and dozens of others — continues to grow as more providers integrate peptide therapy into their practices. The sessions at PWC26 made clear that this growth is not a trend. It is a fundamental shift in how evidence-based medicine is being practiced, and compounding pharmacies are at the center of it.
That’s why our commitment remains unchanged: every API we supply comes with a full Certificate of Analysis, third-party testing documentation, and full chain-of-custody traceability — because the pharmacies we serve, and the patients they treat, deserve nothing less.
What’s Next
The SSRP Institute is hosting a Virtual Summit on July 10–11, 2026 for providers who couldn’t make the in-person event. If you are a pharmacy owner, prescriber, or clinical team member who wants to stay current on peptide therapy developments, we highly recommend exploring their programming at ssrpinstitute.org.
As for MedConnectRx, we will continue attending the industry events that matter most to our pharmacy partners — because understanding your world is how we serve it better.
If you connected with us at PWC26 or want to learn more about our API catalog and pharmacy partnership program, reach out to our team. We would love to continue the conversation.
MedConnectRx is a premier active pharmaceutical ingredient supplier serving licensed compounding pharmacies across the United States. We provide CoA-verified, third-party tested APIs including semaglutide, tirzepatide, BPC-157, NAD+, and more. Contact us to become a verified pharmacy partner.